165 related articles for article (PubMed ID: 15896760)
1. Alterations in alpha adrenoreceptor density and localization after mechanical left ventricular unloading with the Jarvik flowmaker left ventricular assist device.
Grigore A; Poindexter B; Vaughn WK; Nussmeier N; Frazier OH; Cooper JR; Gregoric ID; Buja LM; Bick RJ
J Heart Lung Transplant; 2005 May; 24(5):609-13. PubMed ID: 15896760
[TBL] [Abstract][Full Text] [Related]
2. Location and density of alpha- and beta-adrenoreceptor sub-types in myocardium after mechanical left ventricular unloading.
Schnee PM; Shah N; Bergheim M; Poindexter BJ; Buja LM; Gemmato C; Radovancevic B; Letsou GV; Frazier OH; Bick RJ
J Heart Lung Transplant; 2008 Jul; 27(7):710-7. PubMed ID: 18582798
[TBL] [Abstract][Full Text] [Related]
3. Left ventricular unloading with an assist device results in receptor relocalization as well as increased beta-adrenergic receptor numbers: are these changes indications for outcome?
Bick RJ; Grigore AM; Poindexter BJ; Schnee PM; Nussmeier NA; Gregoric ID; Shah NA; Myers TJ; Buja LM; Frazier OH
J Card Surg; 2005; 20(4):332-6. PubMed ID: 15985133
[TBL] [Abstract][Full Text] [Related]
4. Cardiac transplantation for cardiac sarcoidosis with initial diagnosis by examination of the left ventricular apical "core" excised for insertion of a left ventricular assist device for severe chronic heart failure.
Roberts WC; Vowels TJ; Ko JM; Capehart JE; Hall SA
Am J Cardiol; 2009 Jan; 103(1):110-4. PubMed ID: 19101239
[TBL] [Abstract][Full Text] [Related]
5. Brain natriuretic peptide is produced both by cardiomyocytes and cells infiltrating the heart in patients with severe heart failure supported by a left ventricular assist device.
Bruggink AH; de Jonge N; van Oosterhout MF; Van Wichen DF; de Koning E; Lahpor JR; Kemperman H; Gmelig-Meyling FH; de Weger RA
J Heart Lung Transplant; 2006 Feb; 25(2):174-80. PubMed ID: 16446217
[TBL] [Abstract][Full Text] [Related]
6. Roles of cyclooxygenase-2 and phosphorylated Akt (Thr308) in cardiac hypertrophy regression mediated by left-ventricular unloading.
Wohlschlaeger J; Schmitz KJ; Palatty J; Takeda A; Takeda N; Vahlhaus C; Levkau B; Stypmann J; Schmid C; Schmid KW; Baba HA
J Thorac Cardiovasc Surg; 2007 Jan; 133(1):37-43. PubMed ID: 17198778
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of left ventricular apical tissue removed for HeartMate II left ventricular assist device placement.
Soderlund KA; Chivukula RR; Russell SD; Conte JV; Mudd JO; Halushka MK
Cardiovasc Pathol; 2009; 18(4):217-22. PubMed ID: 18706833
[TBL] [Abstract][Full Text] [Related]
8. The impact of left ventricular assist device-induced left ventricular unloading on the myocardial renin-angiotensin-aldosterone system: therapeutic consequences?
Klotz S; Burkhoff D; Garrelds IM; Boomsma F; Danser AH
Eur Heart J; 2009 Apr; 30(7):805-12. PubMed ID: 19223317
[TBL] [Abstract][Full Text] [Related]
9. Morphological change in myocardium in goat recovered from profound left ventricular failure with cardiac assist device.
Nakamura T
Biomed Mater Eng; 1994; 4(7):487-93. PubMed ID: 7881332
[TBL] [Abstract][Full Text] [Related]
10. Reverse remodeling following insertion of left ventricular assist devices (LVAD): a review of the morphological and molecular changes.
Wohlschlaeger J; Schmitz KJ; Schmid C; Schmid KW; Keul P; Takeda A; Weis S; Levkau B; Baba HA
Cardiovasc Res; 2005 Dec; 68(3):376-86. PubMed ID: 16024006
[TBL] [Abstract][Full Text] [Related]
11. Fluorescence imaging microscopy of cellular markers in ischemic vs non-ischemic cardiomyopathy after left ventricular unloading.
Bick RJ; Bagwell SH; Jones CE; Poindexter BJ; Buja LM; Youker KA; Grigore A; Clubb F; Radovancevic B; Frazier OH
J Heart Lung Transplant; 2005 Apr; 24(4):454-61. PubMed ID: 15797748
[TBL] [Abstract][Full Text] [Related]
12. Left ventricular assist device-induced molecular changes in the failing myocardium.
Soppa GK; Barton PJ; Terracciano CM; Yacoub MH
Curr Opin Cardiol; 2008 May; 23(3):206-18. PubMed ID: 18382208
[TBL] [Abstract][Full Text] [Related]
13. Who would be a candidate for bridge to recovery during prolonged mechanical left ventricular support in idiopathic dilated cardiomyopathy?
Matsumiya G; Monta O; Fukushima N; Sawa Y; Funatsu T; Toda K; Matsuda H
J Thorac Cardiovasc Surg; 2005 Sep; 130(3):699-704. PubMed ID: 16153916
[TBL] [Abstract][Full Text] [Related]
14. Intraoperative transesophageal echocardiography is beneficial for hemodynamic stabilization during left ventricular assist device implantation in children.
Scohy TV; Gommers D; Maat AP; Dejong PL; Bogers AJ; Hofland J
Paediatr Anaesth; 2009 Apr; 19(4):390-5. PubMed ID: 19183405
[TBL] [Abstract][Full Text] [Related]
15. Impact of left ventricular assist device (LVAD) support on the cardiac reverse remodeling process.
Klotz S; Jan Danser AH; Burkhoff D
Prog Biophys Mol Biol; 2008; 97(2-3):479-96. PubMed ID: 18394685
[TBL] [Abstract][Full Text] [Related]
16. Mechanical unloading during left ventricular assist device support increases left ventricular collagen cross-linking and myocardial stiffness.
Klotz S; Foronjy RF; Dickstein ML; Gu A; Garrelds IM; Danser AH; Oz MC; D'Armiento J; Burkhoff D
Circulation; 2005 Jul; 112(3):364-74. PubMed ID: 15998679
[TBL] [Abstract][Full Text] [Related]
17. Assessment of recurrent heart failure associated with left ventricular assist device dysfunction.
Jaski BE; Miller DA; Hoagland PM; Gordon JB; Chillcott SR; Stahovich MJ; Adamson RM; Baradarian S; Dembitsky WP
J Heart Lung Transplant; 2005 Dec; 24(12):2060-7. PubMed ID: 16364850
[TBL] [Abstract][Full Text] [Related]
18. Biventricular assist device-induced right ventricular reverse structural and functional remodeling.
Klotz S; Naka Y; Oz MC; Burkhoff D
J Heart Lung Transplant; 2005 Sep; 24(9):1195-201. PubMed ID: 16143233
[TBL] [Abstract][Full Text] [Related]
19. Effects of centrifugal, axial, and pulsatile left ventricular assist device support on end-organ function in heart failure patients.
Kamdar F; Boyle A; Liao K; Colvin-adams M; Joyce L; John R
J Heart Lung Transplant; 2009 Apr; 28(4):352-9. PubMed ID: 19332262
[TBL] [Abstract][Full Text] [Related]
20. The impact of angiotensin-converting enzyme inhibitor therapy on the extracellular collagen matrix during left ventricular assist device support in patients with end-stage heart failure.
Klotz S; Danser AH; Foronjy RF; Oz MC; Wang J; Mancini D; D'Armiento J; Burkhoff D
J Am Coll Cardiol; 2007 Mar; 49(11):1166-74. PubMed ID: 17367660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
